Athenex, Inc.
ATNXN/A
NASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ATNX News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Metastatic Breast Cancer
1 drug in this indication
Bone-Metastatic, Castration-Resistant Prostate Cancer
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply